MeiraGTx Holdings (MGTX) Change in Receivables (2021 - 2023)
MeiraGTx Holdings' (MGTX) quarterly Change in Receivables came in at $3.6 million in Q2 2023, up 206.16% YoY from $1.2 million in Q2 2022, and up 125.36% on a QoQ basis from -$14.1 million in Q1 2023.
Analysis
MeiraGTx Holdings (MGTX) Change in Receivables (2021 - 2023) Analysis & Trends
MeiraGTx Holdings (MGTX) has 3 years of Change in Receivables data on file, last reported at $3.6 million in Q2 2023.
- Quarterly Change in Receivables rose 206.16% year-over-year to $3.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$15.3 million (changed N/A YoY) and the FY2022 annual result came in at $1.0 million, down 93.7% from the prior year.
- Change in Receivables advanced to $3.6 million in Q2 2023, from -$14.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.2 million in Q1 2022 to a low of -$14.1 million in Q1 2023.
- A 3-year average of -$2.1 million and a median of -$3.4 million in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 206.16% in 2023, down 254.15% in 2023.
- Tracing MGTX's Change in Receivables over 3 years: stood at -$5.1 million in 2021, then soared by 162.48% to $3.2 million in 2022, then climbed by 12.66% to $3.6 million in 2023.
- The last three Change in Receivables figures came in at $3.6 million (Q2 2023), -$14.1 million (Q1 2023), and $3.2 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | -14.14 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | -7.94 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Mar 31, 2022 | 9.17 Mn |
| Dec 31, 2021 | -5.09 Mn |